Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein

Sameer Kumar Malladi(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital), Wafaa B. Alsoussi(Washington University in St. Louis), Wooseob Kim(Korea University), Christopher W Farnsworth(Washington University in St. Louis), Adrianus C. M. Boon, Raffael Nachbagauer(Moderna Therapeutics (United States)), Fangjie Han(Guangzhou University), Julian Q. Zhou(AbCellera (Canada)), Rachel M. Presti(Johns Hopkins University), Stephen Horváth(Washington University in St. Louis), Aaron J. Schmitz(Washington University in St. Louis), William D. Middleton(Mallinckrodt (United States)), Goran Bajic(Icahn School of Medicine at Mount Sinai), Jackson S. Turner(Washington University in St. Louis), Biliana Nestorova(Moderna Therapeutics (United States)), Deepika Jaiswal(Icahn School of Medicine at Mount Sinai), Michael Diamond(Washington University in St. Louis), Bernadeta Dadonaite(Fred Hutch Cancer Center), Darin K. Edwards(Moderna Therapeutics (United States)), Robert Paris(GlaxoSmithKline (United States)), Suzanne M. Scheaffer(Washington University in St. Louis), Michael K. Klebert(Washington University in St. Louis), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Baoling Ying(Washington University in St. Louis), Benjamin S. Strnad(Mallinckrodt (United States)), Alesandro Civljak(Icahn School of Medicine at Mount Sinai), Spyros Chalkias(Moderna Therapeutics (United States))
bioRxiv (Cold Spring Harbor Laboratory)
December 9, 2024
Cited by 2


Related Papers